Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK

Diagnosis and management of headaches in young people and adults: NICE guideline

(2013) Kay Kennis et al.   BRITISH JOURNAL OF GENERAL PRACTICE

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program

(2011) Sheena K. Aurora et al.   HEADACHE

Chronic migraine plus medication overuse headache: two entities or not?

(2011) Andrea Negro et al.   JOURNAL OF HEADACHE AND PAIN

A Case Study for Calculating Employer Costs for Lost Productive Time in Episodic Migraine and Chronic Migraine

(2011) Walter F. Stewart et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine

(2011) R. B. Lipton et al.   NEUROLOGY

Migraine prevalence by age and sex in the United States: A life-span study

(2010) TW Victor et al.   CEPHALALGIA

Vertigo and migraine: A more than two-fold connection

(2010) Andreas Straube et al.   CEPHALALGIA

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

(2010) SK Aurora et al.   CEPHALALGIA

Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

(2010) AM Blumenfeld et al.   CEPHALALGIA

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

(2010) HC Diener et al.   CEPHALALGIA

Chronic Migraine: Epidemiology and Disease Burden

(2010) Aubrey N. Manack et al.   Current Pain and Headache Reports

Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program

(2010) Andrew Blumenfeld et al.   HEADACHE

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

(2010) David W. Dodick et al.   HEADACHE

Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers

(2010) D C Buse et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Global prevalence of chronic migraine: A systematic review

(2009) JL Natoli et al.   CEPHALALGIA

Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study

(2009) Julie Munakata et al.   HEADACHE

Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults

(2008) S Silberstein et al.   CEPHALALGIA

The Importance of Placebo in Headache Research

(2008) H-C Diener et al.   CEPHALALGIA

Direct Cost Burden Among Insured US Employees With Migraine

(2008) Kevin Hawkins et al.   HEADACHE

Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment

(2008) M. E. Bigal et al.   NEUROLOGY